BerGenBio ASA
BRRGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$139,282 | -$190,401 | -$302,122 | -$309,364 |
| Dep. & Amort. | $456 | $223 | $883 | $1,312 |
| Deferred Tax | $0 | $0 | $0 | $668 |
| Stock-Based Comp. | $5,709 | $3,135 | $3,466 | $7,113 |
| Change in WC | -$11,636 | -$33,389 | $9,210 | $61 |
| Other Non-Cash | -$8,489 | -$4,669 | $332 | -$3,130 |
| Operating Cash Flow | -$153,242 | -$225,101 | -$288,231 | -$303,340 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $299 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3,688 | $3,055 | $2,949 | $0 |
| Investing Cash Flow | $3,688 | $3,055 | $3,248 | $3,130 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $138,874 | $262,048 | $3,218 | $16,629 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$9,264 | -$37,164 | -$314 | -$634 |
| Financing Cash Flow | $129,610 | $224,884 | $2,904 | $15,995 |
| Forex Effect | $3,678 | $2,780 | -$3,764 | -$779 |
| Net Chg. in Cash | -$16,266 | $5,618 | -$285,843 | -$284,995 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $156,421 | $150,803 | $436,646 | $721,641 |
| End Cash | $140,155 | $156,421 | $150,803 | $436,646 |
| Free Cash Flow | -$153,242 | -$225,101 | -$288,231 | -$303,340 |